Judge in Illumina vs. Affy IP Infringement Suit Denies Motion to Transfer Case to California | GenomeWeb

By Justin Petrone

The IP infringement suit that Illumina filed against Affymetrix in May will stay in Wisconsin and follow a schedule that calls for a court trial next fall, according to court documents obtained by BioArray News.

In a Sept. 18 order, Magistrate Judge Barbara Crabb of the US District Court for the Western District of Wisconsin denied a motion from Affy's attorneys to transfer the case to the US District Court for the Northern District of California.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.